addiction
Proove Biosciences CEO Exonerated in PGx Test Kickback Case
Proove's founder and CEO was indicted last year on charges the company had defrauded Medicare and violated the Anti-Kickback Statute by paying physicians to use its pharmacogenetic tests.
IVitalize Acquires Genetic Testing Laboratory Geneus Health
Geneus offers a genetic test to identify potential genetic predisposition to reward deficiency syndrome, a primary marker for addiction.
As the circle of doctors ordering drug testing expands, labs find themselves more involved in advisory and interpretive roles that go beyond running assays.
Researchers developing the gene expression-based test say it could bring objectivity to a subjective diagnosis and result in more targeted treatments.
Attis Industries Receives Medicare License for New Toxicology Lab
The Tulsa, Oklahoma-based lab, which received its CLIA license in August, will run samples reimbursed by Medicare and state Medicaid agencies only.